PRF Technologies (PRFX) Long-Term Investments (2022 - 2025)
PRF Technologies (PRFX) posted quarterly Long-Term Investments of $7.6 million for Q4 2025, up 7783.51% year-on-year from $97000.0 in Q4 2024, and up 5.43% on a QoQ basis from $7.3 million in Q2 2025.
PRF Technologies (PRFX) Long-Term Investments (2022 - 2025) Analysis & Trends
PRF Technologies (PRFX) has reported Long-Term Investments for 4 consecutive years, with $7.6 million the latest figure, recorded in Q4 2025.
- Quarterly Long-Term Investments rose 7783.51% year-over-year to $7.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.6 million (up 7783.51% YoY) and the FY2025 annual result came in at $7.6 million, up 7783.51% from the prior year.
- Long-Term Investments improved to $7.6 million in Q4 2025 per PRFX's latest filing, from $7.3 million in the prior quarter.
- Over the last five years, Long-Term Investments for PRFX reached as high as $7.6 million in Q4 2025 and fell as low as $44000.0 in Q4 2022.
- A 4-year average of $2.5 million and a median of $123000.0 in 2023 frame the typical range for Long-Term Investments.
- Annual changes were most pronounced in 2024 — Long-Term Investments declined 25.95% — and 2025, when it soared 7783.51%.
- Year by year, Long-Term Investments stood at $44000.0 in 2022, then surged by 197.73% to $131000.0 in 2023, then dropped by 25.95% to $97000.0 in 2024, then surged by 7783.51% to $7.6 million in 2025.
- According to Business Quant data, Long-Term Investments over the past three periods registered $7.6 million, $7.3 million, and $97000.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 56.09 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.32 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 702.35 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 146.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | PRF Technologies | 745,168.93 | 451,168.93 | - | 7.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.65 Mn |
| Jun 30, 2025 | 7.25 Mn |
| Dec 31, 2024 | 97,000.00 |
| Jun 30, 2024 | 115,000.00 |
| Dec 31, 2023 | 131,000.00 |
| Dec 31, 2022 | 44,000.00 |